Abstract:Fanconi anemia (FA) is caused by pathogenic variants in the FA/BRCA DNA repair pathway genes, and is characterized by congenital abnormalities, bone marrow failure (BMF) and increased cancer risk. We conducted a genotype-phenotype and outcomes study of 203 patients with FA in our cohort. We compared across the genes, FA/BRCA DNA repair pathways (upstream, ID complex and downstream), and type of pathogenic variants (hypomorphic or null). We explored differences between the patients evaluated in our clinic (clinic cohort) and those who provided data remotely (field cohort). Patients with variants in upstream complex pathway had less severe phenotype [lacked VACTERL-H (Vertebral, Anal, Cardiac, Trachea-esophageal fistula, Esophageal/duodenal atresia, Renal, Limb, Hydrocephalus) association and/or PHENOS (Pigmentation, small-Head, small-Eyes, Neurologic, Otologic, Short stature) features]. ID complex was associated with VACTERL-H. The clinic cohort had more PHENOS features than the field cohort. PHENOS was associated with increased risk of BMF, and VACTERL-H with hypothyroidism. The cumulative incidence of severe BMF was 70%, solid tumors (ST) 20% and leukemia 6.5% as the first event. Head and neck and gynecological cancers were the most common ST, with further increased risk after hematopoietic cell transplantation. Among patients with FANCA, variants in exons 27-30 were associated with higher frequency of ST. Overall median survival was 37 years; patients with leukemia or FANCD1/BRCA2 variants had poorest survival. Patients with variants in the upstream complex had better survival than ID or downstream complex (p=0.001 and 0.016, respectively). FA is phenotypically and genotypically heterogeneous; detailed characterization provides new insights towards understanding this complex syndrome and guiding clinical management.

S701 Endoscopic Findings and Intervention Outcomes in Patients With Fanconi Anemia and Esophageal Dysplasia

Esophageal Metastasis from Endometrial Adenocarcinoma: a Case Report and Literature Review

Oral Premalignant and Malignant Lesions in Fanconi Anemia Patients

Two enemies, one fight: An update of oral cancer in patients with Fanconi anemia

Genotype-phenotype and outcome associations in patients with Fanconi anemia: the National Cancer Institute cohort

Oral Squamous Cell Carcinoma In Fanconi Anemia: Case Report.

Benign tumors and non-melanoma skin cancers in patients with Fanconi anemia

Fanconi Anemia in a 31-Year-Old Patient with Multiple Malignant Tumor Foci, Including Appendiceal Cancer, and Multiple Coexisting Pathologies

The Importance Of Oral Cavity Surveillance In Patients With Fanconi Anemia For Early Diagnosis Of Oral Cancer.

Clinical and Genetic Spectrum of Fanconi Anaemia in Australia and New Zealand.

A Case Series: Cancer In Buccal Mucosa In Patients With Fanconi Anemia.

Cisplatin-induced bone marrow failure in an adult patient with Fanconi anemia

Oral Cancer In A Patient With Fanconi Anemia, 28 Years After Hematopoietic Stem Cell Transplantation: Case Report.

Oropharyngeal carcinoma in fanconi anemia patient - Radiation treatment, toxicity, and a year follow-up: Case report

Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations

Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia

Esophageal squamous cell carcinoma at the site of tracheo-esophageal fistula repair in a patient with cystic fibrosis

Bone Marrow Failure in Fanconi Anemia: Clinical and Genetic Spectrum in a Cohort of 20 Pediatric Patients

Phenotypes of adults with Fanconi anaemia

Tongue cancer following hematopoietic cell transplantation for Fanconi anemia

Clinical and biological perspectives on non-canonical esophageal squamous cell carcinoma in rare subtypes